Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900575 · ClinicalTrials.gov registry record · NA
Cervical Cancer Detection Using Optical Spectroscopy
A NA study of Cervical Cancer, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT00900575: Recruiting NA study of Cervical Cancer, sponsored by Duke University.
NCT00900575 is a NA study of Cervical Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 350 participants, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900575, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
Primary Outcome
The primary outcome of this study is the identification of the optical signatures of cervical tissue.
Conditions Studied
Interventions
- DEVICE Optical Spectroscopy Bench-Top System
- DEVICE Portable Optical Spectrometer
- DEVICE Transvaginal colposcope
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2006-05 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT00900575 shows while recruiting
NCT00900575 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 568-participant average among 144 other Cervical Cancer trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 3 interventions - of which Optical Spectroscopy Bench-Top System is the first listed.
NCT00900575 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT00900575 about?
NCT00900575 is a clinical study titled "Cervical Cancer Detection Using Optical Spectroscopy". The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.
What is the current status of trial NCT00900575?
This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2006-05. Estimated completion is 2028-01-31.
What conditions does trial NCT00900575 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00900575?
The interventions under investigation include: Optical Spectroscopy Bench-Top System (DEVICE), Portable Optical Spectrometer (DEVICE), Transvaginal colposcope (DEVICE).
Who is sponsoring clinical trial NCT00900575?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00900575 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00900575's enrollment target sits among peer trials
350 35th of 144 higher than 110 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
- NCT04042259 · 350 participants · NA
Delayed Primary Closure Using Negative Pressure Wound Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia